Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Jordan

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Biochemical and Biophysical Research Communications|February 28, 1979
Highly active heparin species with multiple binding sites for antithrombinR D Rosenberg, R E Jordan, L V Favreau, et al.
Clinical and Experimental Immunology|September 1, 1973
Complement activation in pemphigus vulgaris blister fluidR E Jordan, N K Day, J R Luckasen, et al.
The Journal of Biological Chemistry|November 10, 1980
The binding of low molecular weight heparin to hemostatic enzymesR E Jordan, G M Oosta, W T Gardner, et al.
Archives of Dermatology|November 1, 1990
Dermal mucinosis in the eosinophilia-myalgia syndromeK L Farmer, A A Hebert, R P Rapini, et al.
American Journal of Orthodontics|March 1, 1986
Bonding to porcelain and goldD P Wood, R E Jordan, D C Way, et al.
Biochemical and Biophysical Research Communications|October 16, 1980
The interaction of heparin with thrombin and antithrombinR D Rosenberg, G M Oosta, R E Jordan, et al.
Circulation|September 16, 1998
Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrinsS H Tam, P M Sassoli, R E Jordan, et al.
Angiogenesis|October 1, 2003
Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro)J A Varner, M T Nakada, R E Jordan, et al.
The Journal of Biological Chemistry|November 10, 1980
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparinR E Jordan, G M Oosta, W T Gardner, et al.
The Cochrane Database of Systematic Reviews|May 2, 2001
Laser resurfacing for facial acne scarsR E Jordan, C L Cummins, A J Burls, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|February 28, 1979
Highly active heparin species with multiple binding sites for antithrombinR D Rosenberg, R E Jordan, L V Favreau, et al.
Clinical and Experimental Immunology|September 1, 1973
Complement activation in pemphigus vulgaris blister fluidR E Jordan, N K Day, J R Luckasen, et al.
The Journal of Biological Chemistry|November 10, 1980
The binding of low molecular weight heparin to hemostatic enzymesR E Jordan, G M Oosta, W T Gardner, et al.
Archives of Dermatology|November 1, 1990
Dermal mucinosis in the eosinophilia-myalgia syndromeK L Farmer, A A Hebert, R P Rapini, et al.
American Journal of Orthodontics|March 1, 1986
Bonding to porcelain and goldD P Wood, R E Jordan, D C Way, et al.
Biochemical and Biophysical Research Communications|October 16, 1980
The interaction of heparin with thrombin and antithrombinR D Rosenberg, G M Oosta, R E Jordan, et al.
Circulation|September 16, 1998
Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrinsS H Tam, P M Sassoli, R E Jordan, et al.
Angiogenesis|October 1, 2003
Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro)J A Varner, M T Nakada, R E Jordan, et al.
The Journal of Biological Chemistry|November 10, 1980
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparinR E Jordan, G M Oosta, W T Gardner, et al.
The Cochrane Database of Systematic Reviews|May 2, 2001
Laser resurfacing for facial acne scarsR E Jordan, C L Cummins, A J Burls, et al.
Pageof 12